Table 1 The clinicopathologic features and the expression of immunohistochemical markers in Burkitt lymphoma, High-grade B-cell lymphoma, not otherwise specified and Burkitt-like lymphoma with 11q aberration
From: A combination of LMO2 negative and CD38 positive is useful for the diagnosis of Burkitt lymphoma
| Characteristic | n (%) | ||
|---|---|---|---|
| BL N = 75 | HGBL, NOS N = 12 | 11q N = 3 | |
| Median age (range) | 10(2–69) | 31(1–67) | 15(10–22) |
| Male | 62 (82.67) | 7 (58.33) | 1 (33.33) |
| Intranodal sites | 27 (36.00) | 4 (33.33) | 1 (33.33) |
| LMO-2- | 74 (98.67) | 0 (0.00) | 3 (100.00) |
| CD38+ | 74 (98.67) | 4 (33.33) | 3 (100.00) |
| c-Myc+ | 67 (89.33) | 5 (41.67) | 2 (66.67) |
| Ki67+ | 64 (85.33) | 8 (66.67) | 2 (66.67) |
| BCL-2- | 67 (89.33) | 10 (83.33) | 2 (66.67) |
| MUM1+ | 42 (56.00) | 4 (33.33) | 2 (66.67) |
| BCL6+ | 73 (97.33) | 11 (91.67) | 3 (100.00) |
| CD10+ | 73 (97.33) | 11 (91.67) | 3 (100.00) |